Taxol and embryonic development in the chick

Area of Science:

• Developmental toxicology
• Cancer therapeutics
• Embryology

Background:

• Taxol (paclitaxel) is an anti-cancer drug investigated for its efficacy in treating various human cancers.
• Microtubule disassembly inhibition is Taxol's primary mechanism of action.
• Understanding the developmental toxicity of Taxol is crucial for its therapeutic application.

Purpose of the Study:

• To characterize the potential developmental toxicity of Taxol in chick embryos.
• To investigate the effects of Taxol administration on embryo viability and malformation.
• To explore the role of angiogenesis disruption in Taxol-induced developmental abnormalities.

Main Methods:

• Taxol was administered to chick embryos on days 1-4 of incubation at various doses.
• Gross structural malformations and visceral abnormalities were assessed.
• The effect of Taxol on angiogenesis was evaluated by applying Taxol-soaked filters to the germ disc margin.
• Solvent (DMSO or olive oil) toxicity was considered as a confounding factor.

Main Results:

• High doses of Taxol resulted in a high incidence of early embryo death.
• Gross malformations were sporadic and observed in both Taxol-treated and vehicle-treated embryos.
• A common syndrome of visceral abnormalities (vitelline circulation regression, atrial dilatation, hemorrhage) was observed.
• Taxol did not inhibit vessel development when applied directly to the germ disc, suggesting it does not disrupt angiogenesis.
• Solvent toxicity was identified as a significant confounder.

Conclusions:

• Taxol significantly decreases embryo viability, leading to early death.
• The impairment of embryo survival by Taxol prevents the development of birth defects.
• Solvent toxicity must be carefully considered in studies investigating Taxol's embryotoxicity.